Edge Rewrite
Jump to content

// Workers AI · dad joke modeWhat did Tata 1mg say to the pill? You're a tablet mate.

From Wikipedia, the free encyclopedia
(Redirected from 1mg)

TATA 1mg
TypePrivate
Industry
Founded2015; 11 years ago (2015)
FounderPrashant Tandon
Gaurav Agarwal
Vikas Chauhan
Headquarters,
India
Area served
India
Key people
Prashant Tandon (CEO)
Gaurav Agarwal (CTO)
Vikas Chauhan
Tanmay Saksena (COO)[1]
ProductsMedicine Supply
Healthcare Products
Services
RevenueIncrease 1,968 crore (US$200 million) (2024) [2]
Positive decrease −313 crore (US$−33 million) (2024)
Number of employees
800+ (2021)[3]
ParentTata Digital

Tata 1mg, formerly known as 1mg,[4] is an Indian digital healthcare company headquartered in Gurugram, Haryana. The company provides integrated healthcare services—including e-pharmacy, e-diagnostics, and tele-consultation—through a digital platform and a growing network of physical retail pharmacies and diagnostic laboratories across India.[5][6]

It was founded in April 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan.[5][7] the company has since expanded to include speciality care services covering cancer care,[8][9] obesity management, and at-home adult vaccination, along with private label health and nutrition products and corporate health and wellness programmes.[10][11]

History

[edit]

In 2012, Bright Lifecare Private Limited launched a digital health platform called HealthkartPlus.[12] In 2015, HealthkartPlus was spun off to form 1MG Technologies Private Limited.[13] Healthkart continued as a separate entity focused on fitness and nutrition products; while 1mg operated as a generic drug search and price comparison platform.[14]

The company subsequently developed an online medicine database providing information on drug usage, side effects and generic substitutes, and expanded into home delivery of prescription and over-the-counter medicines as well as diagnostic testing services.[15]

In June 2021, Tata Digital Ltd. acquired a majority stake of approximately 55% in 1mg, after which the platform was rebranded as Tata 1mg and integrated into the Tata Group's digital ecosystem.[16]

In 2023, Tata 1mg was reported to hold approximately 31% of the Indian e-pharmacy market by GMV, making it the largest e-pharmacy platform in India at that time.[17]

In 2024, Tata 1mg and Vitonnix UK jointly introduced Vitamin Sublingual Sprays in Indian market. The first phase of the launch includes vitamin D, multivitamins, biotin, and melatonin.[18]

In December 2025, the company reported positive EBITDA across its core business lines.[6]

Services

[edit]

Tata 1mg provides healthcare services through an omnichannel model, combining a digital platform with a network of physical retail pharmacies and diagnostic laboratories.[6]

ePharmacy

Tata 1mg's e-pharmacy service enables users to order prescription medicines, over-the-counter products, and healthcare essentials.[19] Medicines are sourced from licensed manufacturers and authorised distributors. As of 2026, the service covers more than 20,000 pin codes across India.[6]

eDiagnostics

Tata 1mg's diagnostics service provides home sample collection and laboratory testing through a network of NABL-accredited laboratories.[8] The company operates a National Reference Laboratory in Okhla, New Delhi, which holds accreditation from the College of American Pathologists (CAP).[8]

Retail Pharmacies

Tata 1mg operates a network of physical retail pharmacies across India. As of 2026, the company operates more than 280 retail pharmacy outlets,[6] with plans to expand to approximately 500 outlets by the end of the year.[20]

Specialty Pharma

Tata 1mg offers speciality care services spanning cancer care, obesity management, and at-home adult vaccination, available across multiple cities in India.[8][9][21] These services are designed to support patients requiring ongoing therapy management and access to specialty medicines.

Partnership

[edit]

In March 2022, Tata 1mg made a strategic investment in 5C Network for an undisclosed amount.[22] In May 2025, Tata 1mg partnered with Unicommerce to enhance its e-commerce efficiency across over 1,000 cities in India. The collaboration involved the integration of Unicommerce’s SaaS technology to automate multi-channel order management and warehouse operations.[23]

See also

[edit]

References

[edit]
  1. Chakraborty, Sayan (3 May 2016). "1mg Technologies appoints former Zomato executive Tanmay Saksena as COO". mint.
  2. "Tata 1mg FY24 results". 27 August 2024.
  3. "1mg". Retrieved 6 July 2021.
  4. "Tata Digital to acquire majority stake in 1MG". The Hindu. 11 June 2021. ISSN 0971-751X. Retrieved 16 August 2021.
  5. 1 2 Narasimhan, T. E. (1 March 2019). "Digital healthcare platform IMG Technologies to raise $70 million". Business Standard India. Retrieved 16 August 2021.
  6. 1 2 3 4 5 www.ETPharma.com. "Tata 1mg turns Ebitda positive across operations; plans retail network expansion". ETPharma.com. Retrieved 16 June 2026.
  7. Sil, Debarghya (4 November 2020). "Online Medical and Healthcare Platform 1mg Appoints Mayank Gupta as CFO". Entrepreneur. Retrieved 16 August 2021.
  8. 1 2 3 4 "Tata 1mg turns Ebitda positive across core units as diagnostics crosses Rs 600 crore in ARR". The Economic Times. 27 May 2026. ISSN 0013-0389. Retrieved 16 June 2026.
  9. 1 2 "A Prescription Of Trust | Tata group". www.tata.com. Retrieved 16 June 2026.
  10. Sarkar, Subhojit (27 May 2026). "Tata 1mg turns Ebitda positive across all core businesses in FY26". Fortune India. Retrieved 16 June 2026.
  11. Livemint (27 January 2022). "Mahindra Insurance Brokers partners Tata 1mg for wellness solutions | Company Business News". mint. Retrieved 16 June 2026.
  12. Narasimhan, T. E. (1 March 2019). "Digital healthcare platform IMG Technologies to raise $70 million". Business Standard India. Retrieved 26 July 2021.
  13. Verma, Shrutika (20 April 2015). "Healthkart gets $6 million for spun-off 1MG". mint. Retrieved 26 July 2021.
  14. "Healthkart Separates & Rebrands HealthkartPlus To 1MG, Gets $6 Mn For The Newly Formed Entity". Inc42 Media. 20 April 2015. Retrieved 16 August 2021.
  15. www.ETRetail.com. "Tata 1mg turns EBITDA positive across core units as diagnostics crosses Rs 600 cr in ARR". ETRetail.com. Retrieved 13 July 2026.
  16. "E-health Startup 1mg Gets A $15 Million Booster Dose In Funding". Forbes India. Retrieved 16 August 2021.
  17. Web Team, BS (16 November 2023). "Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy market". Business Standard.
  18. "Tata 1mg & Vitonnix UK enter exclusive partnership in India". The Statesman. 10 January 2024. Retrieved 10 January 2024.
  19. Jani, Jessica (8 November 2024). "A prescription for speed: How e-pharmacies aim to transform medicine delivery". mint. Retrieved 4 August 2026.
  20. "Tata 1mg Announces Major Expansion With Nearly 500 Offline Stores Nationwide". Digital Health News. Retrieved 4 August 2026.
  21. Sarkar, Subhojit (27 May 2026). "Tata 1mg turns Ebitda positive across all core businesses in FY26". Fortune India. Retrieved 4 August 2026.
  22. "Tata1mg makes strategic investment in diagnostic platform 5C Network | Company Business News". mint. 16 March 2022. Retrieved 5 June 2026.
  23. "Tata 1mg partners with Unicommerce to boost e-commerce efficiency across 1000 cities". MediaBrief. 21 May 2025. Retrieved 8 June 2025.